Drugs / Niflec
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02215954 Comparator | Sep → Dec 2014 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Niflec | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02215954 ↗ |
| Route | Oral | “Niflec is a white-yellowish powder for oral solution.” NCT02215954 ↗ |